Low-cost EDA device for screening diabetic neuropathy

被引:2
|
作者
Daniel Bolanos, Luis [1 ]
Maria Vicente-Samper, Jose [2 ]
Zambrana Vinaroz, David [2 ]
Andres Vivas, Oscar [1 ]
Esteve Sala, Vicente [3 ]
Sabater-Navarro, Jose [2 ]
机构
[1] Univ Cauca, Dept Elect Instrumentat & Control, Popayan, Colombia
[2] Miguel Hernandez Univ Elche, nBio Res Grp, Elche, Spain
[3] Univ Alicante, Dept Lenguaje & Sistemas Informat, Alicante, Spain
关键词
Electrodermal activity (EDA); Galvanic skin response (GSR); diabetic neuropathy; Bluetooth Low Energy (BLE); RESPONSES;
D O I
10.1109/CBMS.2019.00061
中图分类号
TP [自动化技术、计算机技术];
学科分类号
0812 ;
摘要
Purpose: Poor electrodermal activity (EDA) may be related to diabetic neuropathy. The aims of this study were to investigate the characteristics of EDA, to design a portable electronic device capable of acquiring it and to formulate a hypothesis regarding the relationship between EDA and diabetic foot. Materials and methods: This study investigated the relationship between EDA signal and diabetic neuropathy using a self-designed device, and tested it with a procedure defined for diabetic foot screening. After that, mean skin conductance level (M-SCL), mean skin conductance response (M-SCR) to stimuli, and difference in mean SCL between feet (DBF) were obtained. Participants were assessed based on whether they had diabetes or not and on their clinical history and care habits. Afterwards, 3 groups were selected, namely reference, people with diabetes out of risk, and people with diabetes at risk of diabetic foot. Results: 22 patients were included in the final test. Several types of stimuli were applied through a test, and responses were recorded and analyzed. Diabetic patients reflected lower MSCL and M-SCR values. Statistical difference was found for those being at risk regarding M-SCR (P<0.01). Conclusion: A test protocol was defined, based on prior tests and measures, to acquire proper and reliable data. Lower SCL and SCR were found according to the diabetes progress. In particular, significant difference was found for M-SCR. No significant difference in DBF values for those at risk was found. These results have the potential to be used as part of a diagnostic tool, which may include other parameters and questionnaires, for diabetic foot screening.
引用
收藏
页码:253 / 258
页数:6
相关论文
共 50 条
  • [1] A Low-Cost, Non-Invasive Sensory Device for Early Diagnosis of Diabetic Peripheral Neuropathy
    Zaffar, Mubariz
    Tariq, Muhammad Taihami
    Arsalan, Muhammad Alp
    Qureshi, Nauman. K.
    Cheema, Hammad M.
    2016 3RD IEEE EMBS INTERNATIONAL CONFERENCE ON BIOMEDICAL AND HEALTH INFORMATICS, 2016, : 196 - 199
  • [2] A Rapid, Low-Cost, Point-of-Care Test for Diabetic Peripheral Neuropathy
    Boettcher, Bonniejean
    Tracey, Brian
    Kong, Xuan
    Williams, Mike
    Gozani, Shai N.
    DIABETES, 2011, 60 : A175 - A175
  • [3] A low-cost spacer device
    Gordon, S
    TROPICAL DOCTOR, 1999, 29 (02) : 116 - 116
  • [4] Wireless Low-Cost Bioimpedance Measurement Device for Lung Capacity Screening
    Pino, Esteban J.
    Gomez, Britam
    Monsalve, Emyrna
    Aqueveque, Pablo
    2019 41ST ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY (EMBC), 2019, : 1187 - 1190
  • [5] Low-Cost Mobile Device for Screening of Atherosclerosis and Coronary Arterial Disease
    Pignatelli, Niccolo
    Ma, Botong
    Sengputa, Shantanu
    Sengupta, Partho
    Mungulmare, Kunda
    Fletcher, Richard Ribon
    2018 40TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY (EMBC), 2018, : 5325 - 5328
  • [6] WINDOWS NT BRINGS UNIFORMITY AND LOW-COST TO EDA
    FUCHS, B
    EDN, 1994, 39 (12) : 162 - &
  • [7] LOW-COST PLATFORMS WILL RESHAPE EDA, SAYS JOY
    MAYER, JH
    COMPUTER DESIGN, 1990, 29 (12): : 17 - 17
  • [8] LOW-COST SCREENING MAMMOGRAPHY
    EVENS, RG
    AMERICAN JOURNAL OF ROENTGENOLOGY, 1992, 159 (02) : 430 - 431
  • [9] LOW-COST BREAST SCREENING
    BIRD, RE
    PRACTICAL MODALITIES OF AN EFFICIENT SCREENING FOR THE EUROPEAN COMMUNITY, 1989, 865 : 111 - 119
  • [10] Cost-effectiveness analysis of the Neuropad device as a screening tool for early diabetic peripheral neuropathy
    B. Rodríguez-Sánchez
    L. M. Peña-Longobardo
    A. J. Sinclair
    The European Journal of Health Economics, 2020, 21 : 335 - 349